Susquehanna International Group, LLP Teva Pharmaceutical Industries LTD Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 91,587 shares of TEVA stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,587

Previous 1,088,253 91.58%

Holding current value

$1.57 Million

Previous $15.4 Million 90.31%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$12.78 - $17.4 $12.7 Million - $17.3 Million	-996,666 Reduced 91.58%	91,587 $1.49 Million
Q1 2024 May 07, 2024	BUY	$10.67 - $14.43 $9.93 Million - $13.4 Million	930,822 Added 591.26%	1,088,253 $15.4 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $8.91 Million - $11.7 Million	-1,097,071 Reduced 87.45%	157,431 $1.64 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $18.9 Million - $27 Million	-2,520,696 Reduced 66.77%	1,254,502 $12.8 Million
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $4.64 Million - $6.1 Million	644,036 Added 20.57%	3,775,198 $28.4 Million
Q1 2023 May 16, 2023	SELL	$8.36 - $11.37 $1.18 Million - $1.6 Million	-141,086 Reduced 4.31%	3,131,162 $27.7 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $441,423 - $526,377	55,525 Added 1.73%	3,272,248 $29.8 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $9.36 Million - $16.3 Million	-1,364,602 Reduced 29.79%	3,216,723 $26 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $8.61 Million - $12.1 Million	-1,167,234 Reduced 20.3%	4,581,325 $34.5 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $38.1 Million - $48.8 Million	-5,192,292 Reduced 47.46%	5,748,559 $54 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $125,523 - $161,908	15,889 Added 0.15%	10,940,851 $87.6 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $3.67 Million - $4.46 Million	437,907 Added 4.18%	10,924,962 $106 Million
Q2 2021 Aug 11, 2021	BUY	$9.9 - $11.56 $19.1 Million - $22.4 Million	1,933,435 Added 22.6%	10,487,055 $104 Million
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $16.6 Million - $20.5 Million	1,602,210 Added 23.05%	8,553,620 $98.7 Million
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $21.1 Million - $27 Million	2,448,516 Added 54.38%	6,951,410 $67.1 Million
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $26.9 Million - $39.8 Million	-3,136,484 Reduced 41.06%	4,502,894 $40.6 Million
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $8.61 Million - $13.9 Million	1,060,915 Added 16.13%	7,639,378 $94.2 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $604,943 - $1.22 Million	-90,425 Reduced 1.36%	6,578,463 $59.1 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $3.23 Million - $5.31 Million	495,043 Added 8.02%	6,668,888 $65.4 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $8.05 Million - $12.5 Million	1,306,927 Added 26.85%	6,173,845 $42.5 Million
Q2 2019 Aug 16, 2019	BUY	$8.12 - $15.72 $5.94 Million - $11.5 Million	731,234 Added 17.68%	4,866,918 $44.9 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $5.87 Million - $11.4 Million	722,383 Added 21.16%	4,135,684 $38.2 Million
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $46.1 Million - $59.1 Million	2,955,986 Added 646.38%	3,413,301 $53.5 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $9.96 Million - $13.2 Million	-596,985 Reduced 56.62%	457,315 $7.82 Million
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $61.2 Million - $104 Million	-5,450,711 Reduced 83.79%	1,054,300 $20 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $100 Million - $209 Million	6,505,011	6,505,011 $114 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Teva Pharmaceutical Industries LTD Transaction History